Covid-19 forces working mothers out of the labour force – leading macroeconomic influencers
Economists believe that in January last year there were more prime-age men than women in employment in the US. However,…
26 Feb 2021
Veteran investor Dr Robert Glassman talks life sciences, immunotherapy and Umoja
Seattle-based pre-clinical biotech Umoja Biopharma aims to revolutionise immunotherapy by retooling the patient’s immune system in vivo. Based on the pioneering work of Seattle Children’s Research Institute and Purdue University,…
25 Feb 2021
Breast cancer research: addressing the premenopausal problem
Although the risk of breast cancer increases with age, the disease can affect young patients too. More than 16,000 American women are diagnosed with the condition before they turn 40,…
24 Feb 2021
Targeting immune diseases: Longwood Fund founds ImmuneID with $17m financing
Precision immunology company ImmuneID has launched with $17m in funding. The financing round was led by founding investor Longwood Fund; other investors participating in the round include XFund and Arch…
24 Feb 2021
Head-to-head: competition heats up as new HIV prevention drug shows promise
Once a certain death sentence, HIV infection has now become a manageable condition. This is due to the introduction of antiretroviral medications that can reduce viral load to the point…
23 Feb 2021
Precision medicine in AMD: SPAC merger sees Gemini make its public debut
Precision medicine-focused Gemini Therapeutics has completed a business combination transaction with Foresite Capital’s special purpose acquisition company (SPAC) FS Development Corp (FDSC). The deal was initiated in October 2021 and…
23 Feb 2021
Biden’s increase of refugees to aid post-Covid economic recovery – leading macroeconomic influencers
Economists believe that increasing the number of refugees into the country could be a great way to drive economic recovery, as the US economy reopens post widely distributed vaccinations. Jonathan…